InterCure Ltd. regained compliance with Nasdaq's minimum bid price requirement following a delisting notice received on September 1, 2026. The company satisfied the rule by maintaining a closing bid price of $1.00 or greater for ten consecutive business days from August 24 through September 4, 2026. This compliance resolves the delisting proceedings initiated due to the stock trading below $1.00 for 30 consecutive days earlier in 2026. InterCure operates in the cannabis industry as Israel's largest licensed producer of pharmaceutical-grade medical cannabis.

On August 12, 2026, InterCure Ltd. entered into a securities purchase agreement for a private placement offering of 1,579,028 units at $2.918 per unit. Each unit consists of one ordinary share and one warrant exercisable at $1.59 per share for five years. The offering was completed on August 25, 2026, generating gross proceeds of approximately $5 million from non-affiliated investors, with an additional expected $2 million from CEO Alexander Rabinovich, whose participation requires shareholder approval. Proceeds will fund working capital and rehabilitate the Nir Oz facility of subsidiary Canndoc Ltd. InterCure Ltd. operates in the cannabis industry, developing and distributing medical marijuana products.

InterCure finalized a settlement with Israeli authorities for NIS 230 million (approximately US$77 million) in compensation for war-related indirect damages stemming from the October 7, 2023 attacks. This amount reduces the company's original claim of over NIS 300 million and follows prior advance payments of NIS 101 million. The settlement allows InterCure to accelerate the rehabilitation of its flagship Canndoc facility at Kibbutz Nir Oz, which was severely damaged in the conflict, aiming to restore full production capabilities. This financial resolution supports the company's strategy to expand into the German medical cannabis market and return to growth following a period of operational recovery. InterCure operates in the medical cannabis industry as Israel’s largest licensed producer.